Molecular Formula | C25H28O6 |
Molar Mass | 424.49 |
Density | 1.140±0.06 g/cm3(Predicted) |
Boling Point | 594.5±50.0 °C(Predicted) |
Solubility | Insuluble (5.1E-3 g/L) (25 °C) |
Appearance | Yellow powder |
Color | yellow |
Storage Condition | 2-8°C |
MDL | MFCD19443859 |
In vitro study | Tetramethylcurcumin (FLLL31; 2.5 and 5 µM;for 24 hours) downregulats STAT3 phosphorylation and DNA-binding activity in MDA-MB-231 breast and PANC-1 pancreatic cancer cells. Tetramethylcurcumin inhibits cell viability, cell invasion. Tetramethylcurcumin is a effective inhibitor of STAT3 phosphorylation, DNA-binding activity, and transactivation in vitro, leading to the impediment of multiple oncogenic processes and the induction of apoptosis in pancreatic and breast cancer cell lines. |
WGK Germany | 3 |
Reference Show more | 1. [IF=7.514] Shuailong Jia et al."Discrimination of turmeric from different origins in China by MRM-based curcuminoid profiling and multivariate analysis."Food Chem. 2021 Feb;338:127794 2. [IF=4.946] Lai Yanni et al."3D-quantitative structure–activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase."Arch Pharm Res. 2020 May;43(5):489-502 |
biological activity | tetramethlencumin (FLLL31) is derived from curcumin, phosphorylation of STAT3 is specifically inhibited by selective binding of Janus kinase 2 and the STAT3 Src homology 2 domain. Tetramethylcurcumin has anti-inflammatory and anti-cancer effects. |